Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...

People with multiple sclerosis (MS) have altered levels of several key bacteria in the mouth, a new study reports.

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

Researchers identified a protein in mouse models that acts as a brake on myelin production, which could be a target for new MS treatments.

As a physician, columnist Susan Payrovi once enjoyed a black-and-white approach to medicine. But MS has forced her to embrace uncertainty.

It’s also worth noting that even if you have MS disability benefits through Social Security, you do not automatically receive ...

Columnist Ben Hofmeister says he's extremely grateful for Ocrevus infusions, which have so far halted his MS disease activity.

If you have SPMS, there are safe, simple, multiple sclerosis-friendly physical activities, as well as exercise routines for MS, you can try.

Having a higher BMI at diagnosis is tied to faster disability progression in people with multiple sclerosis, according to a ...

Secondary progressive multiple sclerosis (SPMS) life expectancy varies widely, depending on factors such as a person’s age at onset, disease severity, overall health, and access to appropriate ...

An MS relapse and the end of a relationship leave columnist Ahna Crum feeling unsafe and unsure about the world around her.

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.